Skip to content

Histopathological study of mechanochemical endovenous ablation of the great saphenous vein

Histopathological study of mechanochemical endovenous ablation of the great saphenous vein - Endovenous histopathological study

Status
Unknown
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON37455
Enrollment
5
Registered
2012-03-28
Start date
Unknown
Completion date
Unknown
Last updated
2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

great saphenous incompetence Varicose veins

Interventions

MOCA is performed in patients with an intact venous circulation, who have been planned for a upper or lower leg amputation due to peripheral arterial disease. The operation is conducted under spinal

Sponsors

Rijnstate Ziekenhuis
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: 1. Elective indication for leg amputation 2. Peripheral arterial disease 3. Age > 18 years 4. Written informed consent

Exclusion criteria

Exclusion criteria: 1. Patient is incapable of informed consent 2. Pregancy and lactation 3. Previous surgical or endovenous treatment of the greater saphenous vein in the amputed leg 4. Great saphenous vein is used for bypass surgery 5. INR > 1.8 6. ASA 5

Design outcomes

Primary

MeasureTime frame
- Occlusion of the treated vein - Depth of damage inside and/or outside the venous wall

Secondary

MeasureTime frame
- Analysis of intraluminal clot / scar - Morphological changes of the saphenous nerve due to damage of treatment - Perivascular damage resulting from treatment

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)